Hui Chen
Affiliations: | 2008-2010 | Mechanical Engineering | Columbia University, New York, NY |
Google:
"Hui Chen"
BETA: Related publications
See more...
Publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
Liu B, Gao S, Guo J, et al. (2024) Efficacy and Safety of HepaSphere Drug-Eluting Bead Transarterial Chemoembolization Combined with Hepatic Arterial Infusion Chemotherapy as the Second-Line Treatment in Advanced Hepatocellular Carcinoma. Journal of Hepatocellular Carcinoma. 11: 477-488 |
Liu B, Gao S, Guo J, et al. (2024) High-dose oxaliplatin induces severe hypersensitivity reactions and high recurrence rates during rechallenge in patients treated with hepatic arterial infusion chemotherapy. International Immunopharmacology. 130: 111767 |
Liu B, Gao S, Guo J, et al. (2023) A Novel Nomogram for Predicting the Overall Survival in Patients with Unresectable HCC after TACE plus Hepatic Arterial Infusion Chemotherapy. Translational Oncology. 34: 101705 |
Feng AW, Guo JH, Gao S, et al. (2022) A randomized phase II trial of hepatic arterial infusion of oxaliplatin plus raltitrexed versus oxaliplatin plus 5-fluorouracil for unresectable colorectal cancer liver metastases. Frontiers in Oncology. 12: 913017 |
Cao G, Wang X, Chen H, et al. (2022) Hepatic arterial infusion chemotherapy plus regorafenib in advanced colorectal cancer: a real-world retrospective study. Bmc Gastroenterology. 22: 328 |
Zheng K, Zhu X, Fu S, et al. (2022) Sorafenib Plus Hepatic Arterial Infusion Chemotherapy versus Sorafenib for Hepatocellular Carcinoma with Major Portal Vein Tumor Thrombosis: A Randomized Trial. Radiology. 211545 |
Liu BJ, Gao S, Zhu X, et al. (2021) Real-world study of hepatic artery infusion chemotherapy combined with anti-PD-1 immunotherapy and tyrosine kinase inhibitors for advanced hepatocellular carcinoma. Immunotherapy |
Chen H, Nan G, Wei D, et al. (2021) Hepatic artery injection of I-metuximab combined with transcatheter arterial chemoembolization for unresectable hepatocellular carcinoma: a prospective non-randomized, multicenter clinical trial. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine |
Liu BJ, Gao S, Zhu X, et al. (2021) Combination Therapy of Chemoembolization and Hepatic Arterial Infusion Chemotherapy in Hepatocellular Carcinoma with Portal Vein Tumor Thrombosis Compared with Chemoembolization Alone: A Propensity Score-Matched Analysis. Biomed Research International. 2021: 6670367 |
Guo JH, Liu SX, Gao S, et al. (2020) Transarterial chemoembolization with hepatic arterial infusion chemotherapy plus S-1 for hepatocellular carcinoma. World Journal of Gastroenterology. 26: 3975-3988 |